White label ELPA - ClinicalTrials.eu

Study of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Small cell lung cancer
Investigated Drugs:
+5
Study on the Effectiveness and Safety of EDP-938 for Adults with High-Risk Respiratory Syncytial Virus (RSV) Infection

Not recruiting

2 1
Investigated Drugs:
- Zelicapavir
Study of Diclofenac compared to Placebo for Pain Relief in Adults with Knee Osteoarthritis

Not recruiting

3 1 1
Investigated Drugs:
- Diclofenac Sodium
Study on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Use of PD L 506 and Aminolevulinic Acid Hydrochloride for New Glioblastoma in Adults

Not recruiting

2 1 1 1
Investigated Diseases:
- Glioblastoma
Investigated Drugs:
- Aminolevulinic Acid Hydrochloride
Study on the Effects of ARO-RAGE (ADS-015) for Patients with Inflammatory Lung Disease

Not recruiting

1 1
Investigated Diseases:
- Asthma
Investigated Drugs:
- Ads-015
Study of Pivekimab Sunirine for Adults with CD123-positive Acute Myeloid Leukemia and Other CD123-positive Blood Cancers

Not recruiting

2 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Pivekimab Sunirine
Study on Stereotactic Body Radiation Therapy with or without Durvalumab for Patients with Oligometastatic Hormone-Sensitive Prostate Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
- Durvalumab
Study on Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed, Refractory, or Newly Diagnosed Multiple Myeloma

Not recruiting

1 1 1 1
Investigated Drugs:
Study on Adjusting Enoxaparin Dose for Children with Kidney Transplants to Prevent Blood Clots

Not recruiting

3 1 1 1
Investigated Diseases:
- Renal transplant
Investigated Drugs:
- Enoxaparin Sodium

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies